{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T01:07:14Z","timestamp":1775005634439,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T00:00:00Z","timestamp":1690329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T00:00:00Z","timestamp":1690329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R41NS117205-01"],"award-info":[{"award-number":["R41NS117205-01"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R41NS117205-01"],"award-info":[{"award-number":["R41NS117205-01"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R41NS117205-01"],"award-info":[{"award-number":["R41NS117205-01"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R41NS117205-01"],"award-info":[{"award-number":["R41NS117205-01"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R41NS117205-01"],"award-info":[{"award-number":["R41NS117205-01"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Spinal Cord"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1038\/s41393-023-00918-x","type":"journal-article","created":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T18:15:56Z","timestamp":1690395356000},"page":"499-504","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Effect of GR205171 on autonomic dysreflexia induced by colorectal distension in spinal cord injured rats"],"prefix":"10.1038","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2314-1108","authenticated-orcid":false,"given":"Nadia M. J.","family":"Rupniak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaoping","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5482-5241","authenticated-orcid":false,"given":"Karl B.","family":"Thor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lesley","family":"Marson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,26]]},"reference":[{"key":"918_CR1","doi-asserted-by":"publisher","first-page":"678","DOI":"10.7326\/0003-4819-44-4-678","volume":"44","author":"NB Kurnick","year":"1956","unstructured":"Kurnick NB. Autonomic hyperreflexia and its control in patients with spinal cord lesions. Ann Intern Med. 1956;44:678\u201386.","journal-title":"Ann Intern Med"},{"key":"918_CR2","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/sc.2014.45","volume":"52","author":"PM Faaborg","year":"2014","unstructured":"Faaborg PM, Christensen P, Krassioukov A, Laurberg S, Frandsen E, Krogh K. Autonomic dysreflexia during bowel evacuation procedures and bladder filling in subjects with spinal cord injury. Spinal Cord. 2014;52:494\u20138. https:\/\/doi.org\/10.1038\/sc.2014.45.","journal-title":"Spinal Cord"},{"key":"918_CR3","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.apmr.2008.10.017","volume":"90","author":"A Krassioukov","year":"2009","unstructured":"Krassioukov A, Warburton DE, Teasell R, Eng JJ. Spinal Cord Injury Rehabilitation Evidence Research Team A systematic review of the management of autonomic dysreflexia after spinal cord injury. Arch Phys Med Rehabil. 2009;90:682\u201395.","journal-title":"Arch Phys Med Rehabil"},{"key":"918_CR4","first-page":"931","volume":"169","author":"J Blackmer","year":"2020","unstructured":"Blackmer J. Rehabilitation medicine: 1. Autonomic dysreflexia. CMAJ 2020;169:931\u20135.","journal-title":"CMAJ"},{"key":"918_CR5","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1002\/nau.20761","volume":"29","author":"WC de Groat","year":"2010","unstructured":"de Groat WC, Yoshimura N. Changes in afferent activity after spinal cord injury. Neurourol Urodyn. 2010;29:63\u201376.","journal-title":"Neurourol Urodyn"},{"key":"918_CR6","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1016\/S0022-5347(05)65183-X","volume":"167","author":"A Giannantoni","year":"2002","unstructured":"Giannantoni A, Di Stasi SM, Stephen RL, Navarra P, Scivoletto G, Mearini E, et al. Intravesical capsaicin versus resiniferatoxin in patients with detrusor hyperreflexia: a prospective randomized study. J Urol. 2002;167:1710\u20134.","journal-title":"J Urol"},{"key":"918_CR7","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1046\/j.1464-410X.2003.04171.x","volume":"91","author":"Y Igawa","year":"2003","unstructured":"Igawa Y, Satoh T, Mizusawa H, Seki S, Kato H, Ishizuka O, et al. The role of capsaicin-sensitive afferents in autonomic dysreflexia in patients with spinal cord injury. BJU Int. 2003;91:637\u201341.","journal-title":"BJU Int"},{"key":"918_CR8","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/0304-3940(82)90029-5","volume":"31","author":"P Holzer","year":"1982","unstructured":"Holzer P, Bucsics A, Lembeck F. Distribution of capsaicin-sensitive nerve fibres containing immunoreactive substance P in cutaneous and visceral tissues of the rat. Neurosci Lett. 1982;31:253\u20137.","journal-title":"Neurosci Lett"},{"key":"918_CR9","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1046\/j.1464-410x.2000.00559.x","volume":"85","author":"H Shaker","year":"2000","unstructured":"Shaker H, Wang Y, Loung D, Balbaa L, Fehlings MG, Hassouna MM. Role of C-afferent fibres in the mechanism of action of sacral nerve root neuromodulation in chronic spinal cord injury. BJU Int. 2000;85:905\u201310.","journal-title":"BJU Int"},{"key":"918_CR10","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1016\/j.juro.2006.08.018","volume":"176","author":"SA Green","year":"2006","unstructured":"Green SA, Alon A, Ianus J, McNaughton KS, Tozzi CA, Reiss TF. Efficacy and safety of a neurokinin-1 receptor antagonist in postmenopausal women with overactive bladder with urge urinary incontinence. J Urol. 2006;176:2535\u201340.","journal-title":"J Urol"},{"key":"918_CR11","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.juro.2010.03.147","volume":"184","author":"TL Frenkl","year":"2010","unstructured":"Frenkl TL, Zhu H, Reiss T, Seltzer O, Rosenberg E, Green S. A multicenter, double-blind, randomized, placebo-controlled trial of a neurokinin-1 receptor antagonist for overactive bladder. J Urol. 2010;184:616\u201322.","journal-title":"J Urol"},{"key":"918_CR12","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1053\/mr.2000.3848","volume":"81","author":"RW Teasell","year":"2000","unstructured":"Teasell RW, Arnold JM, Krassioukov A, Delaney GA. Cardiovascular consequences of loss of supraspinal control of the sympathetic nervous system after spinal cord injury. Arch Phys Med Rehabil. 2000;81:506\u201316.","journal-title":"Arch Phys Med Rehabil"},{"key":"918_CR13","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1002\/cne.21771","volume":"509","author":"S Hou","year":"2008","unstructured":"Hou S, Duale H, Cameron AA, Abshire SM, Lyttle TS, Rabchevsky AG. Plasticity of lumbosacral propriospinal neurons is associated with the development of autonomic dysreflexia after thoracic spinal cord transection. J Comp Neurol. 2008;509:382\u201399.","journal-title":"J Comp Neurol"},{"key":"918_CR14","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/S0306-4522(96)00534-9","volume":"77","author":"IJ Llewellyn-Smith","year":"1997","unstructured":"Llewellyn-Smith IJ, Martin CL, Minson JB, Pilowsky PM, Arnolda LF, Basbaum AI, et al. Neurokinin-1 receptor-immunoreactive sympathetic preganglionic neurons: target specificity and ultrastructure. Neuroscience. 1997;77:1137\u201349.","journal-title":"Neuroscience"},{"key":"918_CR15","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/S0306-4522(96)00599-4","volume":"78","author":"AK Cassam","year":"1997","unstructured":"Cassam AK, Llewellyn-Smith IJ, Weaver LC. Catecholamine enzymes and neuropeptides are expressed in fibres and somata in the intermediate gray matter in chronic spinal rats. Neuroscience. 1997;78:829\u201341.","journal-title":"Neuroscience"},{"key":"918_CR16","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0304-3940(01)01922-X","volume":"307","author":"L Klimaschewski","year":"2001","unstructured":"Klimaschewski L. Increased innervation of rat preganglionic sympathetic neurons by substance P containing nerve fibers in response to spinal cord injury. Neurosci Lett. 2001;307:73\u201376.","journal-title":"Neurosci Lett"},{"key":"918_CR17","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/sc.2010.67","volume":"49","author":"AG Rabchevsky","year":"2012","unstructured":"Rabchevsky AG, Patel SP, Duale H, Lyttle TS, O\u2019Dell CR, Kitzman PH. Gabapentin for spasticity and autonomic dysreflexia after severe spinal cord injury. Spinal Cord. 2012;49:99\u2013105.","journal-title":"Spinal Cord"},{"key":"918_CR18","first-page":"e51914","volume":"92","author":"S Hou","year":"2014","unstructured":"Hou S, Blesch A, Lu P. A radio-telemetric system to monitor cardiovascular function in rats with spinal cord transection and embryonic neural stem cell grafts. J Vis Exp. 2014;92:e51914.","journal-title":"J Vis Exp"},{"key":"918_CR19","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/S0028-3908(03)00157-6","volume":"45","author":"NM Rupniak","year":"2003","unstructured":"Rupniak NM, Carlson EJ, Shepheard S, Bentley G, Williams AR, Hill A, et al. Comparison of the functional blockade of rat substance P (NK1) receptors by GR205171, RP67580, SR140333 and NKP-608. Neuropharmacology. 2003;45:231\u201341.","journal-title":"Neuropharmacology"},{"key":"918_CR20","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ejphar.2003.10.057","volume":"484","author":"PH Hutson","year":"2004","unstructured":"Hutson PH, Patel S, Jay MT, Barton CL. Stress-induced increase of cortical dopamine metabolism: attenuation by a tachykinin NK1 receptor antagonist. Eur J Pharm. 2004;484:57\u201364.","journal-title":"Eur J Pharm"},{"key":"918_CR21","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/0028-3908(94)90004-3","volume":"33","author":"M Jung","year":"1994","unstructured":"Jung M, Calassi R, Maruani J, Barnouin MC, Souilhac J, Poncelet M, et al. Neuropharmacological characterization of SR 140333, a non-peptide antagonist of NK1 receptors. Neuropharmacology. 1994;33:167\u201379.","journal-title":"Neuropharmacology"},{"key":"918_CR22","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/0922-4106(94)90231-3","volume":"267","author":"A Lombet","year":"1994","unstructured":"Lombet A, Spedding M. Differential effects of non-peptidic tachykinin receptor antagonists on Ca2 + channels. Eur J Pharm. 1994;267:113\u20135.","journal-title":"Eur J Pharm"},{"key":"918_CR23","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/S0893-133X(02)00313-5","volume":"27","author":"GB Varty","year":"2002","unstructured":"Varty GB, Cohen-Williams ME, Morgan CA, Pylak U, Duffy RA, Lachowicz JE, et al. The gerbil elevated plus-maze II: anxiolytic-like effects of selective neurokinin NK1 receptor antagonists. Neuropsychopharmacology. 2002;27:371\u20139.","journal-title":"Neuropsychopharmacology"},{"key":"918_CR24","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/0014-2999(94)90809-5","volume":"271","author":"G Smith","year":"1994","unstructured":"Smith G, Harrison S, Bowers J, Wiseman J, Birch P. Non-specific effects of the tachykinin NK1 receptor antagonist, CP-99,994, in antinociceptive tests in rat, mouse and gerbil. Eur J Pharm. 1994;271:481\u20137.","journal-title":"Eur J Pharm"},{"key":"918_CR25","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.euroneuro.2008.06.002","volume":"18","author":"M Brocco","year":"2008","unstructured":"Brocco M, Dekeyne A, Mannoury la Cour C, Touzard M, Girardon S, Veiga S, et al. Cellular and behavioural profile of the novel selective neurokinin 1 receptor antagonist vestipitant: a comparison to other agents. Eur Neuropsychopharmacol. 2008;18:729\u201350.","journal-title":"Eur Neuropsychopharmacol"},{"key":"918_CR26","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1111\/j.1476-5381.1995.tb16686.x","volume":"116","author":"NM Rupniak","year":"1995","unstructured":"Rupniak NM, Webb JK, Williams AR, Carlson E, Boyce S, Hill RG. Antinociceptive activity of the tachykinin NK1 receptor antagonist, CP-99,994, in conscious gerbils. Br J Pharm. 1995;116:1937\u201343.","journal-title":"Br J Pharm"},{"key":"918_CR27","first-page":"472","volume":"267","author":"S McLean","year":"1993","unstructured":"McLean S, Ganong A, Seymour PA, Snider RM, Desai MC, Rosen T, et al. Pharmacology of CP-99,994; a nonpeptide antagonist of the tachykinin neurokinin-1 receptor. J Pharm Exp Ther. 1993;267:472\u20139.","journal-title":"J Pharm Exp Ther"},{"key":"918_CR28","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/0167-0115(96)00071-7","volume":"65","author":"CJ Gardner","year":"1996","unstructured":"Gardner CJ, Armour DR, Beattie DT, Gale JD, Hawcock AB, Kilpatrick GJ, et al. GR205171: a novel antagonist with high affinity for the tachykinin NK1 receptor, and potent broad-spectrum anti-emetic activity. Regul Pept. 1996;65:45\u201353.","journal-title":"Regul Pept"},{"key":"918_CR29","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.4103\/1673-5374.215241","volume":"12","author":"H Sharif","year":"2017","unstructured":"Sharif H, Hou S. Autonomic dysreflexia: a cardiovascular disorder following spinal cord injury. Neural Regen Res. 2017;12:1390\u20131400.","journal-title":"Neural Regen Res"},{"key":"918_CR30","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1136\/pgmj.2004.024463","volume":"81","author":"J Bycroft","year":"2005","unstructured":"Bycroft J, Shergill IS, Choong EAL, Arya N, Shah PJR. Autonomic dysreflexia: a medical emergency. Postgrad Med J. 2005;81:232\u20135.","journal-title":"Postgrad Med J"}],"container-title":["Spinal Cord"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41393-023-00918-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41393-023-00918-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41393-023-00918-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T14:04:16Z","timestamp":1694441056000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41393-023-00918-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,26]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["918"],"URL":"https:\/\/doi.org\/10.1038\/s41393-023-00918-x","relation":{},"ISSN":["1362-4393","1476-5624"],"issn-type":[{"value":"1362-4393","type":"print"},{"value":"1476-5624","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,26]]},"assertion":[{"value":"5 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"NMJR, KBT, and LM are employees and shareholders in Dignify Therapeutics LLC. SF, and SH have no competing interests to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Institutional Animal Care and Use Committee and National Institutes of Health guidelines on animal care to minimize suffering were followed (IACUC PHS Animal Welfare Assurance #A-3222-01, Protocol No: 20839).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}